Compugen (CGEN) Total Liabilities (2009 - 2026)
Compugen's (CGEN) quarterly Total Liabilities came in at $50.5 million in Q1 2026, down 13.42% year-on-year from $58.3 million in Q1 2025, and down 6.19% quarter-over-quarter from $53.8 million in Q4 2025.
Compugen (CGEN) Total Liabilities (2009 - 2026) Analysis & Trends
Compugen has disclosed Total Liabilities across 18 years of filings, most recently posting $50.5 million for Q1 2026.
- Total Liabilities for Q1 2026 came in at $50.5 million, down 13.42% year-over-year; the trailing twelve-month figure through Mar 2026 was $50.5 million (down 13.42% YoY), and the FY2025 annual result was $53.8 million, down 10.39% from the prior year.
- Total Liabilities came in at $50.5 million for Q1 2026 at Compugen, down from $53.8 million in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $63.0 million in Q3 2024 to a low of $14.4 million in Q3 2023.
- The 5-year median for Total Liabilities is $51.8 million (2024), against an average of $40.1 million.
- Across the five-year window, Total Liabilities plunged 35.23% in 2022 and surged 338.18% in 2024, its largest moves.
- Compugen's Total Liabilities stood at $16.5 million in 2022, then soared by 238.11% to $55.8 million in 2023, then grew by 7.72% to $60.1 million in 2024, then dropped by 10.39% to $53.8 million in 2025, then decreased by 6.19% to $50.5 million in 2026.
- The last three Total Liabilities figures came in at $50.5 million (Q1 2026), $53.8 million (Q4 2025), and $54.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1.74 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 15.48 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 16.35 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 731.60 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 10.44 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 19.51 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 943,068.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 7.12 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 137.56 Mn |
| 10 | Compugen | 189.59 Mn | 97.83 Mn | 352,000.00 | 50.51 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 50.51 Mn |
| Dec 31, 2025 | 53.84 Mn |
| Sep 30, 2025 | 54.02 Mn |
| Jun 30, 2025 | 56.27 Mn |
| Mar 31, 2025 | 58.34 Mn |
| Dec 31, 2024 | 60.08 Mn |
| Sep 30, 2024 | 63.03 Mn |
| Jun 30, 2024 | 51.83 Mn |
| Mar 31, 2024 | 54.03 Mn |
| Dec 31, 2023 | 55.78 Mn |
| Sep 30, 2023 | 14.38 Mn |
| Jun 30, 2023 | 15.05 Mn |
| Mar 31, 2023 | 15.11 Mn |
| Dec 31, 2022 | 16.50 Mn |
| Sep 30, 2022 | 19.55 Mn |
| Jun 30, 2022 | 19.93 Mn |
| Mar 31, 2022 | 22.78 Mn |
| Dec 31, 2021 | 25.47 Mn |
| Sep 30, 2021 | 22.47 Mn |
| Jun 30, 2021 | 19.40 Mn |